Arena is the real deal ,Jack is the real broker and Wall Street thus far appears to be the the real loser.
That about sums it up.
besides how could anybody even stoop that low.
Just as well the Postman's so cheerful .
Anyone up for a game of ping pong while we wait?
The way I understand it is phase 3 can now be completed after fast track approval for any drug which exhibits benefits better than existing treatments .
In other words the drug can be sold before completion of phase 3.
Isn't that the purpose of the 21st Century Cures Act .....to bring drugs to market quicker.
Just like everyone thought they would.
But a stock with a pipeline and potential ....well that's a whole different story.
NO ONE wants to sell ,MANY are still to cover while the heavyweights relentlessly continue their quiet accumulation all in the same restricted time frame.
Shares are held tighter than a fish's aas.
The pimps are out in force,working the board around the clock in an attempt to ENLIGHTEN you as to how bad an investment decision YOU have made.
YOU'RE the one who is wrong ,you're the one who fails to understand TIMELINES and FINANCING needs.
And its not just a loathing on Wall Street as some would suggest,it involves an element of Arena shareholders with very large share holdings who would like nothing more than to see the little guy fold while they RETAIN all THEIR shares right up there along side the Institutions.
They are the most vocal and the most greedy.
But the solution may be simpler than they think ...perhaps it is time to scale back THEIR holdings ,loosen their rein,settle for less ,STILL become wealthy BUT in the process hasten the inevitable rise in share price they have been so long hanging out for.....it's simply a case of lowering their sights and looking at it from a different perspective.
Short of such a move patience will be farther tested and tempers farther flare....after all the Institutions aren't going anywhere ,they have all the TIME in the world....while we are finite, they are eternal and that's one very big advantage when it comes to investment and management of time.
Thanks for the heads up on ARNA MB.
Appreciate it and after looking at videos share your enthusiasm .
Some compelling testimonials from Alzheimer patients on video,12 of 14 patients responded,one described it like being in a darkened room and having the light turned on.
And a likely candidate for fast track approval via 21st Century Cures Act .
Unlike Eli Lily's solamezumab which attacks the build up of plaque after the event this drug is directed at the source .
Currently selling for less than 90 cents with just 77 million shares on issue
More stolen identities.
More weasel pss.( I mean seriously ,what sort of a weasel tries to destroy a company for nothing more than his own ill gotten gain ).
Less selling .
Even less selling.
Then before you know it....KABOOM back in time to Jan 7
Instead of stealing someone else's identity and picking pockets.
99% failure rate in the Old timer's space.
Someone related the story, on that board, of Vermilion which he was given a tip on at just 4 cents with the company about to file for bankruptcy.
He didn't buy.....that night the FDA approved their drug and the following day it sold for $1.05 and was selling for $30 within the month.
Moral of the story ,never write off anything and check out all tips.
While other companies seek the limelight, even in instances endorsing their drugs heart benefits before conducting the required safety trials Arena prefers the slow and steady route,proving their drugs through traditional channels with an initial emphasis on safety.
It is to their credit that they are unhurried ,thorough and concerned with the health of patients first and foremost.
Shareholders are frustrated with delays, impatient where the stock price is and embittered by the salaries of senior management .
Which to some extent is understandable,but the question I would ask is which one of you would do a thankless job while taking the associated verbal abuse .
It is par for the course in just about every company listed on US exchanges.
The brilliant CEO's are few and far between and mostly associated with the high revenue producing companies, where to be fair anyone can look good.
It is somewhat similar to politics, when the economy is booming it makes no difference who is in power ,it's hard to stuff up, but in hard times it is a totally different ballgame.
If Lief were to come out tomorrow with a news story that shot the price to $15 there would still be a percentage here who would say it should have been more.
Such is human nature ,it is easy to be critical when you're on the outside looking in.
The people running this company know that in reality everything takes time.
There is endless red tape to deal with,trials to complete,setbacks in drug development ,patents to file,quality control to oversee and competition to contend with.
Nobody said it would be easy ,no one should expect it to be instant,
But the end game is why true longs stay invested while those without fortitude fold.
as a potential means of slowing the progression of the disease.
The drug has exhibited the ability to break down amyloid's,a build up of protein or plaque in the brain which prevent neurotransmitters from performing their normal body function.
Amyloids are directly related to the over supply of insulin.
Given that Alzheimer drugs have a 99% failure rate and the market has 5 million patients seeking treatment in the US alone they are hoping to be the first company to seek FDA approval in 2016.
Needless to say the market potential is in the billions.
And the fall in price was more than 3 times lower to boot.
Hold tight ,something has to give.
77% of shares were held by Institutions and its doubtful they sold at depressed prices.
But they could have unloaded on the run up prior to the news.
With just 27 million shares in retail hands the same shares likely traded today multiple times.
Where the price will settle is anybody's guess ,it could be anywhere between .40 cents and $3.50 and yes its even possible that the news was delivered in the manner it was to #$%$ retail investors
With US securities anything is considered fair game.
I thought it had but my sisters Doctor told her good for mild kidney infection and excellent for Diabetics .
But was happy to refer her to her nephrologist for a second opinion.
down 8 cents.
While ARNA has traded just 470,000 down less than 2 cents.
Sellers are next to non existent....surprise, surprise